Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Do NOD2 and ATG16L1 variants increase Crohn's disease risk and cause malabsorption and diarrhea?

Variants in NOD2 and ATG16L1 increase risk of Crohn's disease, and the resulting intestinal inflammation can impair nutrient absorption and lead to diarrhea.

SupportedJune 19, 202621 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

NOD2 and ATG16L1 variants are associated with increased risk of Crohn’s disease, and intestinal inflammation in Crohn’s can impair nutrient absorption and contribute to diarrhea.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim links NOD2 and ATG16L1 risk variants to higher Crohn's disease susceptibility via impaired bacterial sensing and autophagy that promote chronic intestinal inflammation. That inflammation is framed as causing mucosal damage and transporter dysfunction, which reduce absorption and drive leak-flux, secretory, and osmotic mechanisms of diarrhea.

Verified conclusion

The relationship between genetic susceptibility and the physiological manifestations of Crohn’s disease (CD) is well-established through large-scale genomic studies and clinical pathophysiology.

Genetic susceptibility and risk

Variants in the NOD2 and ATG16L1 genes are among the most significant genetic risk factors for developing Crohn's disease.

  • NOD2 associations: Variants in the NOD2 gene (particularly R702W, G908R, and 1007fs) are strongly linked to CD, with heterozygotes showing a 2- to 4-fold increased risk and homozygotes or compound heterozygotes showing up to a 17- to 38-fold increased risk.
  • ATG16L1 associations: The ATG16L1 T300A variant (rs2241880) is consistently associated with an increased risk of CD, typically with an odds ratio of approximately 1.3 to 1.4 per risk allele.
  • Synergistic effects: Research indicates these genes interact within a shared functional pathway. NOD2 and ATG16L1 are both essential for the body's innate immune response; when these are mutated, the intestine's ability to clear intracellular pathogens via autophagy is impaired, leading to chronic, persistent inflammation.

Mechanisms of malabsorption and diarrhea

Intestinal inflammation in Crohn's disease directly causes nutrient deficiencies and diarrhea through several distinct biological mechanisms.

  • Structural damage: Chronic inflammation can lead to villous atrophy and ulceration, significantly reducing the surface area available for nutrient absorption. This is particularly critical in the terminal ileum, where inflammation can impair the absorption of vitamin B12 and bile acids.
  • Transporter dysfunction: Inflammatory cytokines, such as TNF-α and IL-1β, can downregulate the expression of specific nutrient transporters (e.g., SGLT1 for glucose and PEPT1 for peptides), further hindering the uptake of essential macronutrients and minerals.
  • Secretory and osmotic diarrhea: Diarrhea in CD is multifactorial. It results from "leak-flux" (where impaired tight junctions allow fluid to leak into the intestinal lumen), active chloride secretion driven by inflammatory mediators, and the osmotic effect of unabsorbed nutrients and bile acids remaining in the gut.

Bottom line

The claim is strongly supported by scientific evidence. Variants in NOD2 and ATG16L1 significantly increase Crohn's disease risk by impairing bacterial clearance, while the resulting intestinal inflammation drives both nutrient malabsorption and diarrhea through structural damage and altered cellular transport.

References

  1. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci — nature.com ↗
  2. Gene-Environment Interactions in Inflammatory Bowel Disease: A Systematic Review of Human Epidemiologic Studies — academic.oup.com ↗
  3. Population stratified differences between ATG16L1 rs2241880 polymorphism with Crohn's disease risk: a systematic review and meta-analysis — bmcgastroenterol.biomedcentral.com ↗
  4. OP29 Haematopoietic stem cell gene therapy as a treatment for severe Crohn’s Disease associated with pathogenic NOD2 genetic variants — academic.oup.com ↗
  5. Pathophysiology of IBD associated diarrhea — pmc.ncbi.nlm.nih.gov ↗
  6. Exhaustion profile on classical monocytes after LPS stimulation in patients with Crohn’s disease — biorxiv.org ↗
  7. Blood metabolomic and Crohn’s disease: A Mendelian randomization study — journals.lww.com ↗
  8. Epithelial Transport in Inflammatory Bowel Diseases — pmc.ncbi.nlm.nih.gov ↗
  9. Epithelial Transport in Inflammatory Bowel Diseases — academic.oup.com ↗
  10. Physiology of malabsorption — linkinghub.elsevier.com ↗
  11. Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease — pmc.ncbi.nlm.nih.gov ↗
  12. GPx1 deficiency confers increased susceptibility to ferroptosis in macrophages from individuals with active Crohn’s disease — nature.com ↗
  13. Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease–Associated Diarrhea — pmc.ncbi.nlm.nih.gov ↗
  14. Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease — pmc.ncbi.nlm.nih.gov ↗
  15. DOP027 High-throughput antibody epitope repertoire profiling links NOD2 risk-variants to specific antibody responses in Crohn’s disease — academic.oup.com ↗
  16. P0096 ATG16L1 T300A alters autophagosomal cargoes and modulates inflammation in Crohn’s Disease — academic.oup.com ↗
  17. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. — pmc.ncbi.nlm.nih.gov ↗
  18. Crohn's disease: NOD2, autophagy and ER stress converge — gut.bmj.com ↗
  19. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease — pmc.ncbi.nlm.nih.gov ↗
  20. Intestinal Fibrosis in Crohn’s Disease: Pathophysiology, Diagnosis, and New Therapeutic Targets — mdpi.com ↗
  21. Nutritional management of Crohn’s disease — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→